论文部分内容阅读
报道了原发性肝癌21例,放射治疗11例,Ⅱ期5例,Ⅲ期5例;化疗10例,Ⅱ期5例,Ⅲ期5例。两组治疗结果:放疗组100%获肿瘤缩小和症状改善,而化疗组10%获肿瘤缩小,20%获症状缓解。生存期放疗组平均生存194.7d,最长者达18个月;而化疗组平均生存47.9d,最长者105d。放射治疗效果明显优于化疗。对比两组治疗及生存结果为:放射治疗+肝动脉结扎或插管、栓塞化疗者>单纯放疗者或放疗+化疗+免疫治疗者>单纯化疗者。
There were 21 cases of primary liver cancer, 11 cases of radiotherapy, 5 cases of stage II, 5 cases of stage III, 10 cases of chemotherapy, 5 cases of stage II, and 5 cases of stage III. Two groups of treatment results: 100% of the radiotherapy group had tumor shrinkage and symptoms improved, while 10% of the chemotherapy group received tumor shrinkage, and 20% achieved symptom relief. The average survival time of survival group was 194.7 days, and the longest was 18 months. The average survival time of chemotherapy group was 47.9 days, and the longest was 105 days. Radiotherapy is significantly better than chemotherapy. The treatment and survival results of the two groups were compared: radiotherapy + hepatic artery ligation or intubation, embolization chemotherapy> radiotherapy alone or radiotherapy + chemotherapy + immunotherapy> chemotherapy alone.